26 results
diagnosis endocrinology medications nephrology table comparison differential hyperkalemia potassium treatment dosing dpp4 high inhibitors metformin rheumatology acei acromegaly ada agonists
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents #Diabetes #Diabetic #Medications #Pharmacology #Dosing
Summary of dosing ... recommendations in renal ... #Pharmacology # ... Dosing #Dosing #Renal ... #Impairment #CKD
Summary table of mechanism of action, side effect and contraindications of commonly used diabetic drugs. #pharmacology
Summary table of ... commonly used diabetic ... #pharmacology #dm2 ... #diabetes #medications ... #overview #management
Sulfonylureas - Pharmacology Summary Mechanisms of Action: Binds to the ATP-sensitive potassium channel in pancreatic beta cells,
Sulfonylureas - Pharmacology ... Summary Mechanisms ... contraindicated in CKD ... #Summary #DM2 # ... diabetes #endocrinology
Diabetes Medications Summary Table Insulin Lifestyle modifications Metformin Sulfonylureas GLP-1 receptor agonists - ↓ major adverse CV events TZDs DPP-4 inhibitors SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... Improved outcomes in CKD ... table #comparison #management ... endocrinology #dm2
Metformin Pharmacology Summary Mechanisms of Action: • Suppresses gluconeogenesis by the liver • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... Summary Mechanisms ... agent • Does not cause ... #Summary #DM2 # ... diabetes #endocrinology
Causes of Chronic Kidney Disease - Differential Diagnosis Algorithm Decreased kidney function (eGFR < 60 ml/min/1.73 m2)
Causes of Chronic ... 60 ml/min/1.73 m2 ... 3 months Pre-Renal ... Proteinuria) • Diabetes ... Hyperphosphatemia #CKD
Management of Diabetes Mellitus in Patients With CKD 1. Monitor for changes in BP, serum creatinine, &
Management of Diabetes ... Patients With CKD ... ml/min per 1.73 m2 ... evidence-based pharmacologic ... #Diabetes #CKD #
GLP-1 Receptor Agonists - Pharmacology Summary Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Receptor Agonists - Pharmacology ... Summary Mechanisms ... not definitively cause ... #Summary #DM2 # ... diabetes #endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... Medication Guide Classes ... insulin dose for renal ... #Mellitus #DM2 ... #Medications #pharmacology
Staphylococcus-associated GlomeruloNephritis - Diagnosis and Management Summary CLINICAL • Nephritic syndrome (Casts) • Marked proteinuria (may be
Summary CLINICAL ... Nephritic syndrome (Casts ... • Often severe renal ... lgG or IgA (esp DM ... Follow-up: • CKD
No results found for "Neuropathic Pharmacology diabetes management dm2 summary renal ckd causes"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Neuropathic #Pharmacology #diabetes #management #dm2 #summary #renal #ckd #causes